Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis. Since NAFLD-associated diseases begin with steatosis, the early diagnosis of steatosis helps to prevent the progre...
| Published in: | Clinical and Molecular Hepatology |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2023-02-01
|
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2022-0362.pdf |